Cerebain Biotech Releases Updated Photo of Its First Prototype of the Company's Medical Device Product for Treatment of Alzheimer's

Published: Aug 23, 2013

free biotech news Get the latest biotech news where 

you want it. Sign up for the free GenePool newsletter today!

DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced that medical device product development company, Sonos Models, Inc. (“Sonos”), has provided additional photo of the first prototype of the Company’s medical device solution for the treatment of Alzheimer’s disease utilizing the Omentum. The new photo of the medical device prototype now depicts the electrodes which are intended to provide continuous Omentum stimulation, a novel approach to the treatment for patients suffering from Alzheimer’s disease.

Help employers find you! Check out all the jobs and post your resume.

Back to news